SIA
CVS icon

Strategic Investment Advisors’s CVS Health CVS Stock Holding History

Strategic Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
11,640
+1,899
+19% +$170K 0.07% 130
2026
Q1 		$700K Buy
9,741
+853
+10% +$65.7K 0.05% 185
2025
Q4 		$705K Buy
8,888
+344
+4% +$27.1K 0.06% 131
2025
Q3 		$644K Buy
8,544
+420
+5% +$28.8K 0.06% 139
2025
Q2 		$559K Sell
8,124
-342
-4% -$22.4K 0.05% 152
2025
Q1 		$574K Buy
8,466
+194
+2% +$11.6K 0.06% 150
2024
Q4 		$371K Sell
8,272
-456
-5% -$25.6K 0.04% 197
2024
Q3 		$549K Buy
8,728
+252
+3% +$14.7K 0.06% 170
2024
Q2 		$501K Buy
8,476
+1,896
+29% +$119K 0.06% 178
2024
Q1 		$525K Buy
6,580
+573
+10% +$43.8K 0.07% 170
2023
Q4 		$474K Sell
6,007
-418
-7% -$29.8K 0.07% 172
2023
Q3 		$449K Sell
6,425
-16,412
-72% -$1.16M 0.07% 177
2023
Q2 		$1.58M Sell
22,837
-7,511
-25% -$534K 0.22% 47
2023
Q1 		$2.26M Sell
30,348
-5,609
-16% -$470K 0.41% 40
2022
Q4 		$3.35M Sell
35,957
-144
-0.4% -$13.9K 0.69% 32
2022
Q3 		$3.44M Sell
36,101
-151
-0.4% -$14.9K 0.78% 27
2022
Q2 		$3.36M Buy
36,252
+560
+2% +$54.7K 0.67% 30
2022
Q1 		$3.61M Sell
35,692
-1,925
-5% -$202K 0.68% 30
2021
Q4 		$3.88M Buy
37,617
+24,171
+180% +$2.23M 0.75% 30
2021
Q3 		$1.14M Buy
13,446
+904
+7% +$75.7K 0.25% 77
2021
Q2 		$1.05M Buy
12,542
+5,121
+69% +$419K 0.24% 85
2021
Q1 		$558K Buy
+7,421
New +$541K 0.14% 119

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Strategic Investment Advisors's CVS Position: Q2 2026 in Review

Strategic Investment Advisors increased its CVS Health (CVS) stake by 19% in Q2 2026, buying an estimated $170K and bringing the position to 11,640 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #130.

Strategic Investment Advisors first reported a position in CVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.88M in Q4 2021. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Strategic Investment Advisors held 11,640 shares of CVS Health worth $1.2M as of Q2 2026.
  • Strategic Investment Advisors bought 1,899 CVS Health shares in Q2 2026, an estimated $170K.
  • CVS Health made up 0.07% of Strategic Investment Advisors's portfolio in Q2 2026, its #130 holding.
  • Strategic Investment Advisors first reported a position in CVS Health in Q1 2021 and has held it in 22 quarters since.
  • Strategic Investment Advisors's CVS Health position peaked at $3.88M in Q4 2021.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Strategic Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.